{
    "2020-03-16": [
        [
            {
                "time": "",
                "original_text": "泰格医药拟港联所挂牌，为国内CRO企业A+H第三家",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "港联所",
                        "挂牌",
                        "CRO企业",
                        "A+H"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "泰格医药：拟在香港主板发行H股",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "香港主板",
                        "发行H股"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CRO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}